In focus · trending topic

diabetic macular edema

12 stories · following the connections

Clearside Biomedical, Inc. Added to NASDAQ Biotechnology Index

By Nasdaq OMXDec 14, 2016, 9:15 PM UTC

Clearside Biomedical, Inc. Announces Pricing of Public Offering of Common Stock

By Nasdaq OMXDec 9, 2016, 2:20 PM UTC

Clearside Biomedical, Inc. Announces Proposed Offering of Common Stock

By Nasdaq OMXDec 7, 2016, 9:02 PM UTC

Clearside Biomedical, Inc. Announces First Patient Enrolled in Phase 1/2 Clinical Trial of Zuprata™ in Diabetic Macular Edema

By Nasdaq OMXNov 15, 2016, 1:24 PM UTC